| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,839 |
5,597 |
$352K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,833 |
1,793 |
$188K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,593 |
4,459 |
$144K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,787 |
2,625 |
$96K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,168 |
1,066 |
$89K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,191 |
593 |
$86K |
| 80053 |
Comprehensive metabolic panel |
8,166 |
7,485 |
$64K |
| 80050 |
General health panel |
1,064 |
1,049 |
$49K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
313 |
298 |
$42K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,190 |
8,230 |
$36K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
356 |
333 |
$30K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
371 |
323 |
$27K |
| 80061 |
Lipid panel |
2,142 |
2,108 |
$27K |
| G0378 |
Hospital observation service, per hour |
68 |
63 |
$27K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
674 |
663 |
$22K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
984 |
890 |
$20K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,943 |
2,747 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,612 |
1,546 |
$16K |
| 87070 |
|
2,370 |
2,326 |
$16K |
| 70450 |
Computed tomography, head or brain; without contrast material |
280 |
260 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
295 |
262 |
$13K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
127 |
123 |
$12K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
193 |
168 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,894 |
1,689 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
98 |
87 |
$12K |
| 81001 |
|
4,598 |
4,278 |
$10K |
| 84484 |
|
1,530 |
1,326 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
125 |
122 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,228 |
1,120 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,148 |
1,139 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
258 |
250 |
$8K |
| 84703 |
|
902 |
857 |
$8K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
622 |
597 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
1,409 |
1,272 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
622 |
578 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
347 |
328 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
318 |
293 |
$7K |
| 83880 |
|
327 |
277 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,002 |
979 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
430 |
387 |
$6K |
| 83690 |
|
1,584 |
1,465 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
493 |
459 |
$5K |
| 87186 |
|
623 |
580 |
$5K |
| 87040 |
|
361 |
312 |
$5K |
| 87077 |
|
601 |
563 |
$4K |
| 86618 |
|
181 |
171 |
$4K |
| X0592 |
|
113 |
111 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
274 |
210 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
158 |
141 |
$3K |
| 84439 |
|
436 |
418 |
$3K |
| 83605 |
|
559 |
479 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
125 |
124 |
$3K |
| 82728 |
|
245 |
220 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
123 |
122 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
125 |
122 |
$2K |
| 85379 |
|
290 |
260 |
$2K |
| 87430 |
|
306 |
299 |
$2K |
| 83540 |
|
269 |
256 |
$2K |
| 82607 |
|
175 |
171 |
$2K |
| 85610 |
|
866 |
711 |
$2K |
| 0002A |
|
46 |
46 |
$2K |
| 82150 |
|
445 |
411 |
$2K |
| 85730 |
|
413 |
355 |
$2K |
| 83735 |
|
322 |
271 |
$1K |
| 73630 |
|
129 |
124 |
$1K |
| 82553 |
|
259 |
224 |
$1K |
| 83550 |
|
268 |
255 |
$1K |
| 84145 |
|
115 |
92 |
$1K |
| 82550 |
|
291 |
246 |
$1K |
| 73610 |
|
73 |
68 |
$1K |
| 0001A |
|
42 |
40 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
28 |
27 |
$1K |
| 81003 |
|
341 |
328 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
5,498 |
4,746 |
$1K |
| 85652 |
|
391 |
357 |
$954.02 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
30 |
28 |
$935.74 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25 |
25 |
$907.71 |
| 86140 |
|
363 |
329 |
$840.48 |
| 73030 |
|
81 |
69 |
$830.62 |
| 73110 |
|
74 |
70 |
$780.00 |
| 93971 |
|
17 |
12 |
$675.45 |
| 0071A |
|
13 |
13 |
$572.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
36 |
35 |
$548.18 |
| 82043 |
|
84 |
80 |
$537.11 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
14 |
12 |
$528.94 |
| 84153 |
|
25 |
24 |
$492.37 |
| 76830 |
Ultrasound, transvaginal |
13 |
13 |
$487.25 |
| 86038 |
|
30 |
30 |
$456.00 |
| 83655 |
|
41 |
40 |
$409.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
14 |
$376.74 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
53 |
50 |
$362.13 |
| 97162 |
|
13 |
12 |
$340.35 |
| 73130 |
|
32 |
27 |
$332.62 |
| 87081 |
|
18 |
15 |
$273.82 |
| 73564 |
|
13 |
12 |
$253.80 |
| 86803 |
|
12 |
12 |
$201.40 |
| 88142 |
|
12 |
12 |
$174.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
501 |
473 |
$140.32 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
449 |
391 |
$132.62 |
| 80320 |
|
13 |
12 |
$114.10 |
| 86430 |
|
13 |
13 |
$97.30 |
| 94664 |
|
13 |
12 |
$88.56 |
| 82077 |
|
106 |
97 |
$73.50 |
| J2704 |
Injection, propofol, 10 mg |
124 |
114 |
$56.81 |
| 81002 |
|
13 |
13 |
$51.13 |
| J7050 |
Infusion, normal saline solution, 250 cc |
266 |
191 |
$31.37 |
| 3051F |
|
35 |
35 |
$30.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
414 |
349 |
$28.06 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
76 |
64 |
$20.79 |
| 3044F |
|
151 |
150 |
$20.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
105 |
97 |
$14.83 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
83 |
72 |
$9.80 |
| 96376 |
|
16 |
13 |
$8.28 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
15 |
12 |
$6.85 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
48 |
45 |
$1.91 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
29 |
24 |
$0.00 |
| 3046F |
|
14 |
14 |
$0.00 |
| 91307 |
|
13 |
13 |
$0.00 |